NasdaqCM - Nasdaq Real Time Price USD

Sensus Healthcare, Inc. (SRTS)

Compare
6.42 -0.13 (-1.98%)
At close: October 15 at 4:00 PM EDT
Loading Chart for SRTS
DELL
  • Previous Close 6.55
  • Open 6.53
  • Bid 6.40 x 100
  • Ask 6.47 x 100
  • Day's Range 6.32 - 6.53
  • 52 Week Range 1.79 - 7.18
  • Volume 54,492
  • Avg. Volume 174,485
  • Market Cap (intraday) 105.463M
  • Beta (5Y Monthly) 1.05
  • PE Ratio (TTM) 15.66
  • EPS (TTM) 0.41
  • Earnings Date Nov 7, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 10.67

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

sensushealthcare.com

35

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SRTS

View More

Performance Overview: SRTS

Trailing total returns as of 10/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SRTS
172.03%
S&P 500
21.92%

1-Year Return

SRTS
166.39%
S&P 500
34.37%

3-Year Return

SRTS
57.35%
S&P 500
31.03%

5-Year Return

SRTS
13.83%
S&P 500
96.05%

Compare To: SRTS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SRTS

View More

Valuation Measures

Annual
As of 10/15/2024
  • Market Cap

    105.22M

  • Enterprise Value

    86.94M

  • Trailing P/E

    15.66

  • Forward P/E

    11.78

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.88

  • Price/Book (mrq)

    1.99

  • Enterprise Value/Revenue

    2.39

  • Enterprise Value/EBITDA

    9.70

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    18.27%

  • Return on Assets (ttm)

    9.70%

  • Return on Equity (ttm)

    13.44%

  • Revenue (ttm)

    36.37M

  • Net Income Avi to Common (ttm)

    6.64M

  • Diluted EPS (ttm)

    0.41

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    14.52M

  • Total Debt/Equity (mrq)

    0.87%

  • Levered Free Cash Flow (ttm)

    -2.92M

Research Analysis: SRTS

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 9.24M
Earnings 1.61M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

10.00
10.67 Average
6.42 Current
12.00 High
 

Company Insights: SRTS

People Also Watch